Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry

Fig. 1

Subtype distribution per recruitment year in the etanercept cohort. sJIA, systemic juvenile idiopathic arthritis; RF-neg PA, rheumatoid factor-negative polyarthritis; RF-pos PA, rheumatoid factor-positive polyarthritis; poJIA, persistent oligoarthritis; eoJIA, extended oligoarthritis; ERA, enthesitis-related arthritis; PsA, psoriatic arthritis; unclass JIA, unclassified juvenile idiopathic arthritis

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us